AI model using health records predicts Alzheimer’s disease up to 5 years before diagnosis
By
Kimberly Bonvissuto
Mar 01, 2023
A team of researchers designed an artificial intelligence system that can predict which individuals will develop Alzheimer’s disease up to five years before a diagnosis.
State updates plan to improve access to dementia care
By
Kimberly Bonvissuto
Feb 21, 2024
Rhode Island recently unveiled a five-year update to its state plan to improve access to dementia care as well as improve quality of life for those living with Alzheimer’s disease or another form of...
Proposed bill would ‘destroy dementia training,’ advocates say
By
Kimberly Bonvissuto
May 18, 2023
A proposed bill before the Illinois Legislature would “destroy dementia training” for healthcare providers by reducing education requirements, according to dementia care advocates.
Lawmakers chide HHS for ‘eroding the pathway’ to Alzheimer’s treatments
By
Kimberly Bonvissuto
Mar 24, 2023
With personal stories of the effects that Alzheimer’s disease has had on them, lawmakers in a Senate Finance Committee hearing on Wednesday called for the federal government to speed up access to treatments....
Advocates ‘appalled’ as CMS again says it will not cover monoclonal antibody treatments for Alzheimer’s
By
Kimberly Bonvissuto
Feb 24, 2023
Advocates of those living with Alzheimer’s disease are expressing disappointment that the Centers for Medicare & Medicaid Services on Wednesday rejected a request to expand its coverage of monoclonal...
Alzheimer’s research, treatments prioritized in 2 bills taken up by Congress
By
Kimberly Bonvissuto
Feb 06, 2023
Two bipartisan bills prioritizing Alzheimer’s research and supporting scientists in the development of treatments for the disease were reintroduced in Congress last week.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Progress made in Alzheimer’s research and lifestyle interventions, NIH says
By
Kimberly Bonvissuto
Nov 30, 2022
The burden of Alzheimer’s disease and related dementias is significant, according to the National Institutes of Health. But scientists have made progress in drug development, lifestyle interventions,...
Promising Alzheimer’s drug results hailed as ‘major milestone’
By
Kimberly Bonvissuto
Sep 29, 2022
An investigational drug showing promise in reducing cognitive decline in early Alzheimer’s disease is being hailed as having potential to “change the course” of the disease.